Gotestam Skorpen C, Hoeltzenbein M, Tincani A et al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
However, it is associated with significant incidences of infusion reactions, anaphylaxis, methemoglobinemia, and hemolysis, particularly in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency
doi: 10.1002/mbo3.677 25 PacherP.BeckmanJ
Like BPC-157, TB-500 is scheduled for FDA advisory committee review in July 2026
We couldnt understand this, which is why we looked as many different ways as we could to see if this was a really robust observation, she said